Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tanya A Enderli, Stephanie R Burtch, Jara N Templet & Alessandra Carriero. (2016) Animal models of osteogenesis imperfecta: applications in clinical research. Orthopedic Research and Reviews 8, pages 41-55.
Read now
Read now
Roberta Besio & Antonella Forlino. (2015) Treatment options for osteogenesis imperfecta. Expert Opinion on Orphan Drugs 3:2, pages 165-181.
Read now
Read now
Roberta Besio & Antonella Forlino. (2015) New frontiers for dominant osteogenesis imperfecta treatment: gene/cellular therapy approaches. Advances in Regenerative Biology 2:1.
Read now
Read now
Articles from other publishers (30)
Grégoire André, Antoine Chretien, Antoine Demoulin, Mélanie Beersaerts, Pierre-Louis Docquier & Catherine Behets. (2023) Col1A-2 Mutation in Osteogenesis Imperfecta Mice Contributes to Long Bone Fragility by Modifying Cell-Matrix Organization. International Journal of Molecular Sciences 24:23, pages 17010.
Crossref
Crossref
Long Bai, Yanpeng Liu, Xiaohui Zhang, Peiru Chen, Ruiqiang Hang, Yin Xiao, Jing Wang & Changsheng Liu. (2023) Osteoporosis remission via an anti-inflammaging effect by icariin activated autophagy. Biomaterials 297, pages 122125.
Crossref
Crossref
Natividad Alcorta-Sevillano, Arantza Infante, Iratxe Macías & Clara I. Rodríguez. (2022) Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life. International Journal of Molecular Sciences 24:1, pages 184.
Crossref
Crossref
Fang Lv, Xiaoling Cai & Linong Ji. (2022) An Update on Animal Models of Osteogenesis Imperfecta. Calcified Tissue International 111:4, pages 345-366.
Crossref
Crossref
No’ad Shanas, William Querido, Jack Oswald, Karl Jepsen, Erin Carter, Cathleen Raggio & Nancy Pleshko. (2021)
Infrared Spectroscopy-Determined Bone Compositional Changes Associated with Anti-Resorptive Treatment of the
oim/oim
Mouse Model of Osteogenesis Imperfecta
. Applied Spectroscopy 76:4, pages 416-427.
Crossref
Crossref
Julia Etich, Mirko Rehberg, Beate Eckes, Gerhard Sengle, Oliver Semler & Frank Zaucke. (2020) Signaling pathways affected by mutations causing osteogenesis imperfecta. Cellular Signalling 76, pages 109789.
Crossref
Crossref
Mickaël Cardinal, Alicia Dessain, Thomas Roels, Sébastien Lafont, Michael S. Ominsky, Jean-Pierre Devogelaer, Daniel Chappard, Guillaume Mabilleau, Patrick Ammann, Catherine Nyssen-Behets & Daniel H. Manicourt. (2020) Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice. Calcified Tissue International 106:5, pages 494-508.
Crossref
Crossref
Y. Ko, G. Lee, B. Kim, M. Park, Y. Jang & W. Lim. (2019) Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis. Osteoporosis International 31:5, pages 983-993.
Crossref
Crossref
Peter Varga, Bettina M. Willie, Chris Stephan, Kenneth M. Kozloff & Philippe K. Zysset. (2020) Finite element analysis of bone strength in osteogenesis imperfecta. Bone 133, pages 115250.
Crossref
Crossref
Junho Ahn, Erin Carter, Cathleen L. Raggio & Daniel W. Green. (2019) Acetabular Protrusio in Patients With Osteogenesis Imperfecta: Risk Factors and Progression. Journal of Pediatric Orthopaedics 39:10, pages e750-e754.
Crossref
Crossref
Izaskun Mitxitorena, Arantza Infante, Blanca Gener & Clara I Rodríguez. (2019) Suitability and limitations of mesenchymal stem cells to elucidate human bone illness. World Journal of Stem Cells 11:9, pages 578-593.
Crossref
Crossref
Mickaël Cardinal, Janne Tys, Thomas Roels, Sébastien Lafont, Michael S. Ominsky, Jean-Pierre Devogelaer, Daniel Chappard, Guillaume Mabilleau, Patrick Ammann, Catherine Nyssen-Behets & Daniel H. Manicourt. (2019) Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta. Bone 124, pages 137-147.
Crossref
Crossref
Giacomina Brunetti, Gabriele D’Amato, Mariangela Chiarito, Apollonia Tullo, Graziana Colaianni, Silvia Colucci, Maria Grano & Maria Felicia Faienza. (2018) An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases. World Journal of Pediatrics 15:1, pages 4-11.
Crossref
Crossref
Roy Morello. (2018) Osteogenesis imperfecta and therapeutics. Matrix Biology 71-72, pages 294-312.
Crossref
Crossref
Stacey L. Fossey, John L. Vahle & Joel R. Leininger. 2018. Boorman's Pathology of the Rat. Boorman's Pathology of the Rat
299
319
.
Gwangchul Lee, Youngjong Ko, Mineon Park, Bora Kim, Hoon Hyun & Wonbong Lim. (2018) Recombinant DNA cloning of the active region of the receptor activator of NF-κB ligand (RANKL) gene and its role in osteoclastogenesis. Biotechnology and Bioprocess Engineering 22:6, pages 686-692.
Crossref
Crossref
Ronit Marom, Yi-Chien Lee, Ingo Grafe & Brendan Lee. (2016) Pharmacological and biological therapeutic strategies for osteogenesis imperfecta. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 172:4, pages 367-383.
Crossref
Crossref
Cathleen L Raggio, Nancy Pleshko & Adele L Boskey. (2016) The Effect of Stontium Ranelate on Fracture Reduction in Osteogenesis Imperfecta is Comparable to Recent Bisphosphonate Data. Journal of Bone and Mineral Research 31:11, pages 2065-2065.
Crossref
Crossref
Shinya Takigawa, Brian Frondorf, Shengzhi Liu, Yang Liu, Baiyan Li, Akihiro Sudo, Joseph M. Wallace, Hiroki Yokota & Kazunori Hamamura. (2016) Salubrinal improves mechanical properties of the femur in osteogenesis imperfecta mice. Journal of Pharmacological Sciences 132:2, pages 154-161.
Crossref
Crossref
G. Brunetti, F. Papadia, A. Tummolo, R. Fischetto, F. Nicastro, L. Piacente, A. Ventura, G. Mori, A. Oranger, I. Gigante, S. Colucci, M. Ciccarelli, M. Grano, L. Cavallo, M. Delvecchio & M. F. Faienza. (2016) Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-?. Osteoporosis International 27:7, pages 2355-2365.
Crossref
Crossref
Stacey Fossey, John Vahle, Philip Long, Scott Schelling, Heinrich Ernst, Rogely Waite Boyce, Jacquelin Jolette, Brad Bolon, Alison Bendele, Matthias Rinke, Laura Healy, Wanda High, Daniel Robert Roth, Michael Boyle & Joel Leininger. (2016) Nonproliferative and Proliferative Lesions of the Rat and Mouse Skeletal Tissues (Bones, Joints, and Teeth). Journal of Toxicologic Pathology 29:3_Suppl, pages 49S-103S.
Crossref
Crossref
Adele L. Boskey, Josephine Marino, Lyudmila Spevak, Nancy Pleshko, Stephen Doty, Erin M. Carter & Cathleen L. Raggio. (2015) Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?. Clinical Orthopaedics and Related Research? 473:8, pages 2587-2598.
Crossref
Crossref
Robert O. Ritchie. (2014) In pursuit of damage tolerance in engineering and biological materials. MRS Bulletin 39:10, pages 880-890.
Crossref
Crossref
Alessandra Carriero, Elizabeth A Zimmermann, Adriana Paluszny, Simon Y Tang, Hrishikesh Bale, Bjorn Busse, Tamara Alliston, Galateia Kazakia, Robert O Ritchie & Sandra J Shefelbine. (2014) How Tough Is Brittle Bone? Investigating Osteogenesis Imperfecta in Mouse Bone. Journal of Bone and Mineral Research 29:6, pages 1392-1401.
Crossref
Crossref
Eric S. Orwoll & Elizabeth Martin. 2014. Osteogenesis Imperfecta. Osteogenesis Imperfecta
519
525
.
Charlotte L. Phillips, Stephanie M. Carleton & Bettina A. Gentry. 2014. Osteogenesis Imperfecta. Osteogenesis Imperfecta
197
207
.
Xiaomei Yao, Stephanie M. Carleton, Arin D. Kettle, Jennifer Melander, Charlotte L. Phillips & Yong Wang. (2013) Gender-Dependence of Bone Structure and Properties in Adult Osteogenesis Imperfecta Murine Model. Annals of Biomedical Engineering 41:6, pages 1139-1149.
Crossref
Crossref
Marianne Rohrbach & Cecilia Giunta. (2012) Recessive osteogenesis imperfecta: Clinical, radiological, and molecular findings. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 160C:3, pages 175-189.
Crossref
Crossref
R. Bargman, R. Posham, A. L. Boskey, E. DiCarlo, C. Raggio & N. Pleshko. (2011) Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta. Osteoporosis International 23:3, pages 1141-1150.
Crossref
Crossref
Antonella Forlino, Wayne A. Cabral, Aileen M. Barnes & Joan C. Marini. (2011) New perspectives on osteogenesis imperfecta. Nature Reviews Endocrinology 7:9, pages 540-557.
Crossref
Crossref